Jessica Paulicelli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study).
Journal: Infectious diseases and therapy
Published: December 22, 2025
Prevalence of Circulating Autoantibodies Against G-Protein-Coupled Receptors as Potential Biomarkers for Long COVID: Preliminary Investigations.
Journal: International journal of molecular sciences
Published: December 14, 2025
Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy).
Journal: Human vaccines & immunotherapeutics
Published: November 06, 2025
Corrigendum to "Humoral and T-cell responses following MVA-BN booster vaccination against mpox virus clades Ib and IIb" [J Infect 91 (2025) 106602].
Journal: The Journal of infection
Published: October 10, 2025
Salivary cortisol in long COVID: a marker of broader stress system and circadian rhythm dysregulation.
Journal: Frontiers in cellular and infection microbiology
Published: August 22, 2025
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study).
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 11, 2025
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease.
Journal: Scientific reports
Published: March 07, 2025
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine.
Journal: International journal of molecular sciences
Published: March 07, 2025
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route.
Journal: Vaccines
Published: November 06, 2024
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 29, 2024
Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: October 25, 2024
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition.
Journal: AIDS (London, England)
Published: July 02, 2024
Last Updated: 09/26/2026